Welcure Drugs & Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 736142, "name": "Welcure Drugs", "stock_name": "Welcure Drugs", "full_name": "Welcure Drugs & Pharmaceuticals Ltd", "name_url": "stocks-analysis/welcure-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "0.25", "chg": -0.01, "chgp": "-3.85%", "dir": -1, "prev_price": "0.26", "mcapval": "32.00 Cr", "mcap": "Micro Cap", "scripcode": 524661, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE331C01025", "curr_date": "Jun 29, 03:30 PM", "curr_time": "18:14 PM", "last_traded_at": "Jun 29, 03:30 PM IST", "bse_nse_vol": "19.03 lacs", "exc_status": "Active", "traded_date": "Jun 29, 2026", "traded_date_str": "2026 06 29", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/welcure-drugs-736142-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-strong-sell-4063161", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/WelcureDrugsPha_mojoScore_4063161.png", "date": "2026-06-19 10:10:31", "description": "Welcure Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 19 June 2026, providing investors with an up-to-date view of the company’s position." }, { "title": "Welcure Drugs Declines 10.34%: Downgrade and Valuation Risks Weigh on Stock", "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-declines-1034-downgrade-and-valuation-risks-weigh-on-stock-4052273", "imagepath": "", "date": "2026-06-13 17:13:34", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Downgrade to Strong Sell announced</p>\n <p><strong>2 June:</strong> Valuation metrics signal elevated risk</p>\n <p><strong>5 June:</strong> Week closes at Rs.0.26 (-10.34%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.0.29</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.0.26</div><div class=\"stat-change negative\">-10.34%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week High</div><div class=..." }, { "title": "Welcure Drugs & Pharmaceuticals Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-downgraded-to-strong-sell-amidst-deteriorating-financial-and-technical-metrics-4030257", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/WelcureDrugsPha_mojoScore_4030257.png", "date": "2026-06-02 09:03:59", "description": "Welcure Drugs & Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating as of 1 June 2026, reflecting deteriorating fundamentals and technical indicators. The micro-cap pharmaceutical company’s financial trend has shifted from positive to flat, valuation metrics have worsened to risky territory, and technical signals have turned bearish, signalling heightened caution for investors." }, { "title": "Welcure Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Elevated Risk Amidst Market Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-valuation-shifts-signal-elevated-risk-amidst-market-underperformance-4029320", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/WelcureDrugsPha_valuationdot_4029320.png", "date": "2026-06-02 08:03:18", "description": "Welcure Drugs & Pharmaceuticals Ltd has experienced a marked deterioration in its valuation parameters, shifting from very attractive to risky territory, as reflected in its price-to-earnings and price-to-book value ratios. This change, coupled with a significant decline in share price and underperformance relative to the Sensex, raises concerns about the stock’s price attractiveness and investment appeal within the Pharmaceuticals & Biotechnology sector." }, { "title": "Welcure Drugs Q4 FY26: Massive Loss Wipes Out Year's Gains", "link": "https://www.marketsmojo.com/news/result-analysis/welcure-drugs-q4-fy26-massive-loss-wipes-out-years-gains-4024049", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/WelcureDrugsPha_quaterlyResult_4024049.png", "date": "2026-05-30 20:20:53", "description": "Welcure Drugs & Pharmaceuticals Ltd. reported a catastrophic fourth quarter for FY26, posting a net loss of ₹49.86 crores compared to a profit of ₹2.54 crores in the same quarter last year. The micro-cap pharmaceutical company's shares, trading at ₹0.29 on the NSE, have plunged 73.15% over the past year, reflecting investor alarm over the dramatic deterioration in operational performance." }, { "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-4016588", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/WelcureDrugsPha_mojoScore_4016588.png", "date": "2026-05-27 10:10:30", "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3987417", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/WelcureDrugsPha_mojoScore_3987417.png", "date": "2026-05-12 10:10:03", "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3959074", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/WelcureDrugsPha_mojoScore_3959074.png", "date": "2026-04-23 10:10:04", "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 14 Nov 2025, reflecting a change in the company’s outlook at that time. However, all fundamentals, returns, and financial metrics discussed below are current as of 23 April 2026, providing an up-to-date view of the stock’s position in the market." }, { "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3939481", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/WelcureDrugsPha_mojoScore_3939481.png", "date": "2026-04-09 10:10:18", "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." } ], "total": 298, "sid": "736142", "stock_news_url": "https://www.marketsmojo.com/news/welcure-drugs-pharmaceuticals-736142" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer", "datetime": "19-Jun-2026", "details": "Resignation of Company Secretary and Compliance Officer", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday 19Th June 2026", "datetime": "19-Jun-2026", "details": "Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on Today i.e. Friday 19th June 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "01-Jun-2026", "details": "Newspaper Clipping of Audited Financials Results for the 4th Quarter and Annual year ended 31st March 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 16 Oct 25", "dt": "2025-10-16", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 16 Oct 25", "dt": "2025-10-16", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Downgrade to Strong Sell announced

2 June: Valuation metrics signal elevated risk

5 June: Week closes at Rs.0.26 (-10.34%)

Read full news article

Welcure Drugs & Pharmaceuticals Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Metrics

2026-06-02 09:03:59

Welcure Drugs & Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating as of 1 June 2026, reflecting deteriorating fundamentals and technical indicators. The micro-cap pharmaceutical company’s financial trend has shifted from positive to flat, valuation metrics have worsened to risky territory, and technical signals have turned bearish, signalling heightened caution for investors.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Elevated Risk Amidst Market Underperformance

2026-06-02 08:03:18

Welcure Drugs & Pharmaceuticals Ltd has experienced a marked deterioration in its valuation parameters, shifting from very attractive to risky territory, as reflected in its price-to-earnings and price-to-book value ratios. This change, coupled with a significant decline in share price and underperformance relative to the Sensex, raises concerns about the stock’s price attractiveness and investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

Welcure Drugs Q4 FY26: Massive Loss Wipes Out Year's Gains

2026-05-30 20:20:53

Welcure Drugs & Pharmaceuticals Ltd. reported a catastrophic fourth quarter for FY26, posting a net loss of ₹49.86 crores compared to a profit of ₹2.54 crores in the same quarter last year. The micro-cap pharmaceutical company's shares, trading at ₹0.29 on the NSE, have plunged 73.15% over the past year, reflecting investor alarm over the dramatic deterioration in operational performance.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-05-27 10:10:30

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-05-12 10:10:03

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-04-23 10:10:04

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 14 Nov 2025, reflecting a change in the company’s outlook at that time. However, all fundamentals, returns, and financial metrics discussed below are current as of 23 April 2026, providing an up-to-date view of the stock’s position in the market.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-04-09 10:10:18

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article